A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
Thomas Jefferson University
Thomas Jefferson University
ModernaTX, Inc.
Fred Hutchinson Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Louisville
Enzon Pharmaceuticals, Inc.